Literature DB >> 25338421

Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.

Sivakumar Ardhanari, Martin A Alpert, Kul Aggarwal.   

Abstract

Patients with chronic kidney disease (CKD) experience serious adverse cardiovascular (CV) consequences. Cardiovascular disease is the leading cause of morbidity and mortality in patients with CKD, being secondary not only to an increased prevalence of traditional CV risk factors, but also to the presence of a wide array of nontraditional risk factors unique to patients with CKD. Pathogenesis includes both functional and structural alterations in the CV system. Those alterations give rise to a wide range of clinical CV syndromes, including ischemic heart disease, heart failure, and sudden cardiac arrest. As an increasingly prevalent disease, CKD, together with consequent CV disease, imparts major health and economic burdens to the community. In this review, we discuss traditional and nontraditional risk factors for CV disease, the pathogenesis of CV clinical syndromes, and prevention of CV syndromes in patients with CKD.

Entities:  

Mesh:

Year:  2014        PMID: 25338421

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  11 in total

Review 1.  Cardiovascular risk factors following renal transplant.

Authors:  Jill Neale; Alice C Smith
Journal:  World J Transplant       Date:  2015-12-24

2.  The association between platelet indices and cardiovascular events in chronic kidney disease patients without dialysis.

Authors:  Zhikai Yu; Jiachuan Xiong; Ke Yang; Yinhui Huang; Ting He; Yanlin Yu; Jinghong Zhao
Journal:  Int Urol Nephrol       Date:  2021-01-02       Impact factor: 2.370

3.  Novel regulations of MEF2-A, MEF2-D, and CACNA1S in the functional incompetence of adipose-derived mesenchymal stem cells by induced indoxyl sulfate in chronic kidney disease.

Authors:  Duyen Thi Do; Nam Nhut Phan; Chih-Yang Wang; Zhengda Sun; Yen-Chang Lin
Journal:  Cytotechnology       Date:  2016-08-22       Impact factor: 2.058

4.  Awareness and Knowledge Among Internal Medicine House-Staff for Dose Adjustment of Cardiovascular Drugs in Chronic Kidney Disease.

Authors:  Kyla D'Angelo; Svetlana Paul; Fnu Ranjeeta; Joshua Fogel; Daniel Chikvashvili; Sofia Rubinstein
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-02-24

5.  Intelligent Diagnostic Prediction and Classification System for Chronic Kidney Disease.

Authors:  Mohamed Elhoseny; K Shankar; J Uthayakumar
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

6.  Evaluation of Statin Use and Prescribing in Patients with Chronic Kidney Disease Not Receiving Treatment with Kidney Transplant or Dialysis.

Authors:  Hilary Wu; Mazen Sharaf; Karen Shalansky; Nadia Zalunardo
Journal:  Can J Hosp Pharm       Date:  2021-07-01

Review 7.  Computational Models Used to Predict Cardiovascular Complications in Chronic Kidney Disease Patients: A Systematic Review.

Authors:  Alexandru Burlacu; Adrian Iftene; Iolanda Valentina Popa; Radu Crisan-Dabija; Crischentian Brinza; Adrian Covic
Journal:  Medicina (Kaunas)       Date:  2021-05-27       Impact factor: 2.430

8.  Pharmacological induction of ferritin prevents osteoblastic transformation of smooth muscle cells.

Authors:  Gergely Becs; Abolfazl Zarjou; Anupam Agarwal; Katalin Éva Kovács; Ádám Becs; Mónika Nyitrai; Enikő Balogh; Emese Bányai; John W Eaton; Paolo Arosio; Maura Poli; Viktória Jeney; József Balla; György Balla
Journal:  J Cell Mol Med       Date:  2015-10-26       Impact factor: 5.310

9.  Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran.

Authors:  Marzieh Bakhshayeshkaram; Jamshid Roozbeh; Seyed Taghi Heidari; Behnam Honarvar; Mohammad Hossein Dabbaghmanesh; Kamran B Lankarani
Journal:  Int J Endocrinol Metab       Date:  2019-02-27

10.  Speckle-tracking echocardiography in comparison with ejection fraction for prediction of cardiovascular mortality in patients with end-stage renal disease.

Authors:  Janna Terhuerne; Merel van Diepen; Rafael Kramann; Johanna Erpenbeck; Friedo Dekker; Nikolaus Marx; Jürgen Floege; Michael Becker; Georg Schlieper
Journal:  Clin Kidney J       Date:  2021-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.